drugset / Trial / NCT02618057

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

NCT02618057

Phase 4 Unknown 80 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children.

Timeline

Start
2016-06
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 1 mg/kg Oral
Background Levofloxacin Small molecule 10 mg/kg Intravenous